WEBULL
WebtradeDownload

IDEX (IEX) Backlog Growth Keeps Undervalued View In Play Following A Strong Run

Simply Wall St · 2d ago

IDEX (IEX) has drawn investor attention after recent share price swings, with the stock last closing at US$233.86. The business spans health and science technologies, fluid and metering solutions, and fire and safety products worldwide.

Recent trade has cooled slightly, with the share price slipping about 0.7% over the last day and 0.8% over the past week. However, the 30.6% year to date share price return and 42.3% one year total shareholder return suggest momentum has been building rather than fading.

Scan beyond IDEX and review hand picked industrials showing strong momentum and fundamentals with the list of solid balance sheet and fundamentals (25 results).

IDEX now trades about 17% below an estimated intrinsic value and roughly 10% under the average analyst target after a strong run. Is that discount a genuine opportunity, or a signal the market is wary for a reason?

Most Popular Narrative: 9% Undervalued

On the most followed view of IDEX, a fair value of about $255.93 sits above the recent $233.86 close. This puts the current discount in focus for anyone tracking the story.

Record company backlog of more than US$1b with 28% organic order growth in Q2 2026 and multi quarter visibility in HST and parts of FMT, including future dated data center bookings that extend into 2027, provides a pipeline that can support revenue and cash flow growth beyond what is already recognised.

See why 8 investors see IDEX as 9% undervalued.

Result: Fair Value of $255.93 (UNDERVALUED)

Still, the IDEX story can change quickly if policy shocks hit orders or if external research on softer organic growth and returns proves to be closer to reality.

Find out about the key risks to this IDEX narrative.

Another View On IDEX: Rich Multiple, Different Message

There is a catch. On simple P/E maths, IDEX trades at about 33.2x earnings, above both the US Machinery industry on 24.2x and its own fair ratio of 22.9x. That kind of gap can flag valuation risk if earnings do not keep up with the optimism already in the price.

For a closer look at how the current price stacks up against this earnings multiple and the fair ratio, review the See what the numbers say about this price — find out in our valuation breakdown..

NYSE:IEX P/E Ratio as at Oct 2026
NYSE:IEX P/E Ratio as at Oct 2026

Next Steps

Momentum and valuation signals around IDEX split opinion, so move quickly, check the numbers yourself, and weigh how the 3 key rewards fits your own thesis.

Looking for more investment ideas beyond IDEX?

If IDEX has sharpened your focus on quality, do not stop here. Broader opportunity sits in other corners of the market that match different goals.